NO985325D0 - Anvendelse av substituert azaspiran ved behandling av astma - Google Patents

Anvendelse av substituert azaspiran ved behandling av astma

Info

Publication number
NO985325D0
NO985325D0 NO985325A NO985325A NO985325D0 NO 985325 D0 NO985325 D0 NO 985325D0 NO 985325 A NO985325 A NO 985325A NO 985325 A NO985325 A NO 985325A NO 985325 D0 NO985325 D0 NO 985325D0
Authority
NO
Norway
Prior art keywords
azaspiran
asthma
substituted
treatment
substituted azaspiran
Prior art date
Application number
NO985325A
Other languages
English (en)
Other versions
NO985325L (no
Inventor
Mary Alison Badger
John Gerald Gleason
Original Assignee
Anormed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anormed Inc filed Critical Anormed Inc
Publication of NO985325D0 publication Critical patent/NO985325D0/no
Publication of NO985325L publication Critical patent/NO985325L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO985325A 1996-05-17 1998-11-16 Anvendelse av substituert azaspiran ved behandling av astma NO985325L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1788996P 1996-05-17 1996-05-17
PCT/IB1997/000688 WO1997044030A1 (en) 1996-05-17 1997-05-15 Use of substituted azaspirane in the treatment of asthma

Publications (2)

Publication Number Publication Date
NO985325D0 true NO985325D0 (no) 1998-11-16
NO985325L NO985325L (no) 1998-11-16

Family

ID=21785110

Family Applications (1)

Application Number Title Priority Date Filing Date
NO985325A NO985325L (no) 1996-05-17 1998-11-16 Anvendelse av substituert azaspiran ved behandling av astma

Country Status (17)

Country Link
US (1) US6025364A (no)
EP (1) EP0910373A1 (no)
JP (1) JP2000513335A (no)
KR (1) KR20000010933A (no)
CN (1) CN1219129A (no)
AU (1) AU710542B2 (no)
BR (1) BR9709007A (no)
CA (1) CA2253217A1 (no)
CZ (1) CZ367598A3 (no)
HU (1) HUP0003908A3 (no)
IL (1) IL127040A0 (no)
NO (1) NO985325L (no)
NZ (1) NZ332627A (no)
PL (1) PL329931A1 (no)
SK (1) SK156698A3 (no)
WO (1) WO1997044030A1 (no)
ZA (1) ZA974271B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004080408A2 (en) * 2003-03-10 2004-09-23 Callisto Pharmaceuticals, Inc. Method of treating cancer with azaspirane compositions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963557A (en) * 1987-09-28 1990-10-16 Smithkline Beecham Corporation Immunomodulatory azaspiranes
CA2092177A1 (en) * 1990-09-24 1992-03-25 Alison Mary Badger Methods
ZA921120B (en) * 1991-02-19 1993-01-27 Smithkline Beecham Corp Cytokine inhibitors
US5482959A (en) * 1992-01-28 1996-01-09 Smithkline Beecham Corporation Method for delaying aids in an HIV infected individual by administration of substituted azaspirane compounds
GB9315340D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods
GB9315306D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods
GB9315351D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods

Also Published As

Publication number Publication date
CN1219129A (zh) 1999-06-09
AU2973997A (en) 1997-12-09
HUP0003908A3 (en) 2001-04-28
NO985325L (no) 1998-11-16
PL329931A1 (en) 1999-04-26
EP0910373A1 (en) 1999-04-28
JP2000513335A (ja) 2000-10-10
WO1997044030A1 (en) 1997-11-27
KR20000010933A (ko) 2000-02-25
CA2253217A1 (en) 1997-11-27
US6025364A (en) 2000-02-15
ZA974271B (en) 1998-08-25
AU710542B2 (en) 1999-09-23
BR9709007A (pt) 2000-01-04
CZ367598A3 (cs) 1999-05-12
HUP0003908A2 (en) 2001-03-28
NZ332627A (en) 2001-06-29
IL127040A0 (en) 1999-09-22
SK156698A3 (en) 1999-06-11

Similar Documents

Publication Publication Date Title
NO991955L (no) FremgangsmÕte for behandling av hydrokarboner
NO991381L (no) Kombinasjonsterapi for behandling av psykoser
NO995095D0 (no) Substituerte imidazoler nyttig ved behandlingen av inflammasjonssykdommer
PT796628E (pt) Inalador
DK0841946T4 (da) Metoder til behandling af allergisk astma
ID15858A (id) Turunan triazol yang berguna dalam terapi
BR9708797A (pt) Processo de preparação de partículas as respectivas partículas e utilização das mesmas
NO20001412D0 (no) Sammensetninger og fremgangsmåter ved behandling av respiratoriske forstyrrelser
ZA979731B (en) Treatment of asthma.
NO991619D0 (no) Anvendelse av en H+, K+-ATPase-inhibitor i behandlingen av nesepolypper
NO995723L (no) Nye triptolidderivater som er anvendbare ved behandling av autoimmune sykdommer
NO995722D0 (no) Nye triptolidderivater som er anvendbare ved behandling av autoimmune sykdommer
ID19542A (id) Pengobatan baru
ZA973843B (en) Treatment of asthma with TNFR-lg.
NO985325D0 (no) Anvendelse av substituert azaspiran ved behandling av astma
DE59711240D1 (de) Verwendung von flupirtin zur therapie und prophylaxe von myokardinfarkt, schockniere und schocklunge
NO962503D0 (no) Anvendelse av penoksyfyllin ved behandling av multippel sklerose
NO986053L (no) Anticonvulsivt virkende derivater for anvendelse ved behandling av psoriasis
GB9726223D0 (en) The treatment of materials
NO942686D0 (no) Anvendelse av 3-arylindol- og 3-arylindazolderivater ved behandling av psykoser
KR960011173U (ko) 연사기에 있어 스핀들의 이중 펀 카바
NO954115D0 (no) Anvendelse av ceruletid-dietylaminsalt ved behandling av psoriasis
FI970269A0 (fi) 1,3-diolipohjaisten esterien seokset, menetelmä 1,3-diolipohjaisten esterien valmistamiseksi sekä esterien käyttö
KR950026706U (ko) 치료용 발열기
KR980000917U (ko) 당구용 초크

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application